These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10890474)

  • 41. Lepirudin for cardiopulmonary bypass surgery in a patient with terminal renal insufficiency and acute heparin-induced thrombocytopenia.
    Riess FC; Dobritzsch B; Kormann J
    Thorac Cardiovasc Surg; 2006 Mar; 54(2):140-2. PubMed ID: 16541359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heparin-induced thrombocytopenia and the use of r-hirudin during cardiopulmonary bypass.
    Manikappa S; Benfield K; Gan TE; Butler J; Malan E; Tran HA; Tucker A
    Anaesth Intensive Care; 2005 Jun; 33(3):388-92. PubMed ID: 15973924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ecarin clotting time but not aPTT correlates with PEG-hirudin plasma activity.
    Moser M; Ruef J; Peter K; Kohler B; Gulba DC; Paterna N; Nordt T; Kübler W; Bode C
    J Thromb Thrombolysis; 2001 Oct; 12(2):165-9. PubMed ID: 11729368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical monitoring of hirudin and direct thrombin inhibitors.
    Nowak G
    Semin Thromb Hemost; 2001 Oct; 27(5):537-41. PubMed ID: 11668425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of three methods for measuring PEG-hirudin in blood.
    Hoffmann JJ; Janssen WC
    Blood Coagul Fibrinolysis; 2001 Oct; 12(7):577-81. PubMed ID: 11685047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sensitivity of a modified ACT test to levels of bivalirudin used during cardiac surgery.
    Zucker ML; Koster A; Prats J; Laduca FM
    J Extra Corpor Technol; 2005 Dec; 37(4):364-8. PubMed ID: 16524153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of a new point of care heparin test for cardiopulmonary bypass: the TAS heparin management test.
    Wallock M; Jeske WP; Bakhos M; Walenga JM
    Perfusion; 2001 Mar; 16(2):147-53. PubMed ID: 11334198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of an acute flush reaction caused by subcutaneous r-hirudin with pegylated hirudin.
    Harenberg J; Hoffmann U; Huhle G; Song XH; Wang LC
    Br J Haematol; 2000 Mar; 108(3):528-30. PubMed ID: 10759710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bleeding after intermittent or continuous r-hirudin during CVVH.
    Kern H; Ziemer S; Kox WJ
    Intensive Care Med; 1999 Nov; 25(11):1311-4. PubMed ID: 10654220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monitoring anticoagulant therapy by activated partial thromboplastin time: hirudin assessment. An evaluation of native blood and plasma assays.
    Nurmohamed MT; Berckmans RJ; Morriën-Salomons WM; Berends F; Hommes DW; Rijnierse JJ; Sturk A
    Thromb Haemost; 1994 Nov; 72(5):685-92. PubMed ID: 7900075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hirudin as anticoagulant for cardiopulmonary bypass: importance of preoperative renal function.
    Koster A; Pasic M; Bauer M; Kuppe H; Hetzer R
    Ann Thorac Surg; 2000 Jan; 69(1):37-41. PubMed ID: 10654482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the TAS coagulation analyzer for monitoring heparin effect in cardiac surgical patients.
    Gibbs NM; Weightman WM; Thackray NM; Michalopoulos N
    J Cardiothorac Vasc Anesth; 1998 Oct; 12(5):536-41. PubMed ID: 9801974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparin-induced thrombocytopenia.
    Saad RA
    N Engl J Med; 2006 Dec; 355(24):2598; author reply 2598-9. PubMed ID: 17167148
    [No Abstract]   [Full Text] [Related]  

  • 54. Hirudin versus heparin for anticoagulation in continuous renal replacement therapy.
    Vargas Hein O; von Heymann C; Lipps M; Ziemer S; Ronco C; Neumayer HH; Morgera S; Welte M; Kox WJ; Spies C
    Intensive Care Med; 2001 Apr; 27(4):673-9. PubMed ID: 11403068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A quick anti-Xa-activity-based whole blood coagulation assay for monitoring unfractionated heparin during cardiopulmonary bypass: a pilot investigation.
    Hansen R; Koster A; Kukucka M; Mertzlufft F; Kuppe H
    Anesth Analg; 2000 Sep; 91(3):533-8. PubMed ID: 10960371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant hirudin.
    Koster A; Kuppe H; Hetzer R; Sodian R; Crystal GJ; Mertzlufft F
    Anesthesiology; 1998 Sep; 89(3):777-80. PubMed ID: 9743416
    [No Abstract]   [Full Text] [Related]  

  • 57. A novel method for the direct determination of heparin concentration during cardiopulmonary bypass surgery.
    Haselbach S; Maurer J; Vogel V; Harder S; Weber CF; Baykut D; Meininger D; Keller H; Moritz A; Mäntele W
    Clin Chem Lab Med; 2013 Oct; 51(10):2037-43. PubMed ID: 23798620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ecarin clotting time is sensitive to heparinoids: comparison of two different techniques.
    Demir M; Iqbal O; Untch B; Hoppensteadt DA; Gaikwad BS; Fareed J
    Clin Appl Thromb Hemost; 2001 Jan; 7(1):38-43. PubMed ID: 11190903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ecarin chromogenic assay--a new method for quantitative determination of direct thrombin inhibitors like hirudin.
    Lange U; Nowak G; Bucha E
    Pathophysiol Haemost Thromb; 2003 Jul-2004 Aug; 33(4):184-91. PubMed ID: 15583447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anticoagulation in extracorporeal circulation using recombinant hirudin: a case report.
    Beholz S; Grubitzsch H; Bergmann B; Wollert HG; Eckel L
    Perfusion; 2000 Jun; 15(3):257-60. PubMed ID: 10866429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.